Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Health care industry Companies Breaking News: Business
From CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Breaking News: Europe Europe News Pharmaceuticals
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Politics Europe Politics Europe Economy
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags Pharmaceuticals Novo Nordisk A/S Breaking News: Politics
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags LILLY DRN Social issues Health & Science
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Abbvie Inc Business Biotechnology
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Novo Nordisk A/S Make It: Next Gen Investing Make It / Money
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Novo Nordisk A/S Health care industry Enterprise
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags Business Stock markets Shopify Inc
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Abbvie Inc Biotechnology LILLY DRN
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Health & Science Business Biotechnology
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Biotechnology Business Health & Science
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags Business Biotechnology Health & Science
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Pfizer Inc Health care industry Healthy Returns
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Stellantis NV AP Moeller / Maersk A/S Oil and Gas
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Viking Therapeutics Inc Companies Health care industry
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags Daily Open JPMorgan Chase & Co Novo Nordisk A/S
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags LILLY DRN US: News Health & Science
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Europe Markets Politics Luxury
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Health & Science Biotechnology Business
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags Europe Economy Kering SA AstraZeneca PLC
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Bavarian Nordic A/S Bayer AG Roche Holding AG
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotechnology Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Markets Market Outlook World Markets
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Microstrategy Inc Daily Open SAP AG
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Science LILLY DRN Social issues
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags Europe Markets Breaking News: Markets LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.